Cited by 1,411Lipoproteins and Cardiovascular HealthLipid metabolism and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Open access

Austin, M A, King, M C, Vranizan, K M, Krauss, R M·1990·Circulation

DOI 10.1161/01.cir.82.2.495

Open this paper in CoChat — free account Open PDF

Abstract

In a community-based study of 301 subjects from 61 nuclear families, two distinct phenotypes (denoted A and B) were identified by nondenaturing gradient gel electrophoretic analysis of low density lipoprotein (LDL) subclasses. Phenotype A was characterized by predominance of large, buoyant LDL particles, and phenotype B consisted of a major peak of small, dense LDL particles. Previous analysis of the family data by complex segregation analysis demonstrated that these phenotypes appear to be inherited as a single-gene trait. In the present study, the phenotypes were found to be closely associated with variations in plasma levels of other lipid, lipoprotein, and apolipoprotein measurements. Specifically, phenotype B was associated with increases in plasma levels of triglyceride and apolipoprotein B, with mass of very low and intermediate density lipoproteins, and with decreases in high density lipoprotein (HDL) cholesterol, HDL2 mass, and plasma levels of apolipoprotein A-I. Thus, the proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.82.2.495

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,111
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,895
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,885
Applied linear statistical models : regression, analysis of variance, and experimental designs
Neter, J., Wasserman, W., & Kutner, M. (1974) · Andalas University Repository (Andalas University) · Cited by 2,818
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415

Show all 63 references

Research works printed but not linked: 13

Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364
Heiss G, Tyroler HA: Are apolipoproteins useful for evaluat- ing ischemic heart disease? A brief overview of the literature, in Lippel K (ed): Proceeding ofthe Workshop on Apolipoprotein Quantification. National Institutes of Health publication No. (NIH) 83-1266, 1983, pp 7-19
Krauss RM, Lindgren FT, Williams PT, Kelsy SF, Brensike J, Vranizan K, Detre KM, Levy RI: Intermediate density lipo- proteins and coronary artery disease progression in hypercho- lesterolemic men. Lancet 1987;2:62-66
Ernst N, Fisher M, Smith W, Gordon W, Rifkind BM, Little JA, Mishkel MA, Williams DO: The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption: The Lipid Research Clinics Program Prevalence Study. Circulation: 1980;62:41-52
Lindgren FT, Jensen LC, Hatch FT: The isolation and quan- titative analysis of serum lipoproteins, in Nelson GJ (ed): Blood Lipids and Lipoproteins. New York, Wiley Interscience, 1972, pp 181-274
Morton NE, Rao DC, Lalouel JM: Methods in genetic epi- demiology, in Klingberg MA (ed): Contributions to Epidemiol- ogy and Biostatistics. Basel, Karger, vol 4, 1983, pp 62-102
Snedecor GW, Cochran WG: Statistical Methods, ed 6. Ames, Iowa, Iowa State University Press, 1967
SAS Users Guide: Basics, Version 5 Edition.
SAS User Guide: Statistics, Version 5 Edition.
Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangeiwaia S: Triglyceride and Coronary Heart Disease Mortal- ity. The Lipid Research Clinics Follow-up Study presented at the American Heart Association 27th Conference on Cardio- vascular Disease Epidemiology, Chapel Hill, NC, 1987
Steiner G, Schwartz L, Shumak S, Poapst M: The association of increased levels of intermediate density lipoproteins with smoking and coronary heart disease. Circulation 1987; 75:124-130
Swinkels DW, Demacker PNM, Hendricks JCM, van t'Laar A: Low density lipoprotein subfractions and relationship to other risk factors in healthy individuals. Arteriosclerosis 1989; 9:604-613
Krauss RM, Albers JJ, Brunzell JD: An apolipoprotein B- enriched low density lipoprotein subspecies in familial com- bined hyperlipidemia. Clin Res 1983;31:503a

Sorted by citations

Items 301–400 of 1,000

Very-low-carbohydrate weight-loss diets revisited.
Volek, J. S., & Westman, E. C. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.11.849 · Cited by 77
Clinical Relevance of Non-HDL Cholesterol in Patients With Diabetes
Peters, A. L. (2008) · Clinical Diabetes · doi:10.2337/diaclin.26.1.3 · Cited by 78
Who needs to care about small, dense low-density lipoproteins?
Rizzo, M., & Berneis, K. K. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01596.x · Cited by 77
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria
Gazi, I. F., Tsimihodimos, V., Filippatos, T. D., Bairaktari, E. T., Tselepis, A. D., & Elisaf, M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.015 · Cited by 75
Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study
Freedman, D. S., Bowman, B. A., Otvos, J. D., Srinivasan, S. R., & Berenson, G. S. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00495-5 · Cited by 77
Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease
Gratacós, E. (2000) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(00)00427-9 · Cited by 77
“[45] Austin MA, King MC, Vranizan KM, Krauss RM.”
Background
The tangled web of coronary risk factors
Krauss, R. M. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90035-v · Cited by 77
Self-citation
Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women
Campos, H., Sacks, F. M., Walsh, B. W., Schiff, I., O’Hanesian, M. A., & Krauss, R. M. (1993) · Metabolism · doi:10.1016/0026-0495(93)90273-q · Cited by 77
Self-citation
LDL physical and chemical properties in familial combined hyperlipidemia
Hokanson, J. E., Krauss, R. M., Albers, J. J., Austin, M. A., & Brunzell, J. D. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.452 · Cited by 76
Self-citation
Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study)
Engler, M. M., Engler, M. B., Malloy, M. J., Paul, S. M., Kulkarni, K. R., & Mietus-Snyder, M. L. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.12.014 · Cited by 76
Associations between Small Dense LDL, HDL Subfractions (HDL2, HDL3) and Risk of Atherosclerosis in Japanese-Americans
Maeda, S., Nakanishi, S., Yoneda, M., Awaya, T., Yamane, K., Hirano, T., & Kohno, N. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11445 · Cited by 76
Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100
ABATEA, N., Vega, G., & Grundy, S. M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90187-y · Cited by 76
Atherogenic dyslipidemia: Lipoprotein abnormalities and implications for therapy
Grundy, S. M. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80011-g · Cited by 76
Dyslipidemia in Non-Insulin-Dependent Diabetes Mellitus
Howard, B. V., & Howard, W. J. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-263 · Cited by 76
Physical activity and postprandial lipidemia: Are energy expenditure and lipoprotein lipase activity the real modulators of the positive effect?
Peddie, M. C., Rehrer, N. J., & Perry, T. L. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.002 · Cited by 75
“This occurs, not only through the direct accumulation of chylomicrons into arterial walls, but also because the high TG environment promotes the development of a more atherogenic lipid profile [5].”
Background
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
Rizzo, M., Pernice, V., Frasheri, A., & Berneis, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.034 · Cited by 75
“[4] Austin MA, King MC, Vranizan KM, Krauss RM.”
Background
Dyslipidemia in diabetes mellitus
Yoshino, G., Hirano, T., & Kazumi, T. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01263-6 · Cited by 75
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis
Rizzo, M., Spinas, G. A., Cesur, M., Özbalkan, Z., Rini, G. B., & Berneis, K. K. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.015 · Cited by 75
A Hepatic Lipase Gene Promoter Polymorphism Attenuates the Increase in Hepatic Lipase Activity With Increasing Intra-abdominal Fat in Women
Carr, M. C., Hokanson, J. E., Deeb, S. S., Purnell, J. Q., Mitchell, E. S., & Brunzell, J. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2701 · Cited by 74
Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects
Brodt-Eppley, J., White, P., Jenkins, S. H., & Hui, D. Y. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00083-g · Cited by 75
Pleiotropic Genetic Effects on LDL Size, Plasma Triglyceride, and HDL Cholesterol in Families
Edwards, K. L., Mahaney, M. C., Motulsky, A. G., & Austin, M. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2456 · Cited by 75
Self-citation
Prepregnancy Body Mass Index and Gestational Age-Dependent Changes in Lipid Levels During Pregnancy
Vahratian, A. M., Misra, V. K., Trudeau, S., & Misra, D. P. (2010) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181e45d23 · Cited by 74
Lipid Triad or Atherogenic Lipoprotein Phenotype: A Role in Cardiovascular Prevention?
Rizzo, M., & Berneis, K. K. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.237 · Cited by 74
Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März, W., Baumstark, M. W., Scharnagl, H., Ruzicka, V., Buxbaum, S. G., Herwig, J., Pohl, T., Russ, A., Schaaf, L., & Berg, A. ‐. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116915 · Cited by 74
“Increased concentrations of small dense LDL usually occur in combination with low HDL and high triglycerides, the triad being referred to as the "atherogenic lipoprotein phenotype" (47, 48).”
Background
Differences in postprandial lipaemic response between Northern and Southern Europeans
Zampelas, A., Roche, H. M., Knapper, J. M. E., Jackson, K. G., Tornaritis, M. J., Hatzis, C., Gibney, M. J., Kafatos, A., GOULD, B. J., Wright, J., et al. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00061-6 · Cited by 74
Significance of small dense low-density lipoproteins and other risk factors in patients with various types of coronary heart disease
Koba, S., Hirano, T., Kondo, T., Shibata, M., Suzuki, H., Murakami, M., Geshi, E., & Katagiri, T. (2002) · American Heart Journal · doi:10.1067/mhj.2002.126119 · Cited by 73
Candidate-Gene Studies of the Atherogenic Lipoprotein Phenotype: A Sib-Pair Linkage Analysis of DZ Women Twins
Austin, M. A., Talmud, P. J., Luong, L.-A., Haddad, L., Day, I. N. M., Newman, B. M., Edwards, K. L., Krauss, R. M., & Humphries, S. E. (1998) · The American Journal of Human Genetics · doi:10.1086/301712 · Cited by 72
Self-citation
Translational value of animal models of obesity—Focus on dogs and cats
Osto, M., & Lutz, T. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.036 · Cited by 79
“…particles is strongly associated with an increased risk of coronary artery disease and the development of atherosclerosis in nondiabetic patients (Austin et al., 1990), and the sdLDL phenotype is also a consistent feature in insulin resistant subjects. sd-LDLs are thought to be highly…”
Background
Lipid-Lowering Drugs in the Management of Hyperlipidaemia
Bhatnagar, D. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00018-7 · Cited by 74
Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns
Dreon, D. M., Fernstrom, H. A., Williams, P. T., & Krauss, R. M. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1611 · Cited by 72
Self-citation
Effect of Diabetes on Lipoprotein Size
Singh, A. T. K., Rainwater, D. L., Haffner, S. M., VandeBerg, J. L., Shelledy, W. R., Moore, P. H., & Dyer, T. D. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1805 · Cited by 72
Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia
Allayee, H., Dominguez, K. M., Aouizerat, B. E., Krauss, R. M., Rotter, J. I., Lu, J., Cantor, R. M., de Bruin, T. W., & Lusis, A. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32058-7 · Cited by 72
Self-citation
Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome
O’Neill, B. J. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000569 · Cited by 72
“The atherogenic triad is completed with small dense LDL (sd-LDL-P) [17].”
Background
THE OPTIMAL RATIO OF FAT-TO-CARBOHYDRATE IN THE DIET
Grundy, S. M. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.325 · Cited by 71
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis
TOMKIN, G. H., & Owens, D. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.179 · Cited by 71
“[122] who demonstrated a relationship between small dense LDL as de®ned by gel electrophoresis and coronary artery disease.”
Background
Medical Management of Hyperlipidemia/Dyslipidemia
Kreisberg, R. A., & Oberman, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030388 · Cited by 72
The Clinical Relevance of Low-Density-Lipoproteins Size Modulation by Statins
Rizzo, M., & Berneis, K. K. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-8283-x · Cited by 71
“In addition, small, dense LDL, with elevated triglyceride levels and low HDL-cholesterol concentrations, constitute the Batherogenic lipoprotein phenotype,’’ a form of atherogenic dyslipidemia that is a feature of type 2 diabetes and the metabolic syndrome [7, 8].”
Background
Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women.
Williams, P., VRANIZAN, K. M., & Krauss, R. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41440-3 · Cited by 70
Self-citation
Serum lipid concentrations among persons with spinal cord injury – A systematic review and meta-analysis of the literature
Gilbert, O. N., Croffoot, J. R., Taylor, A. J., Nash, M. S., Schomer, K. G., & Groah, S. L. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.028 · Cited by 69
The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The cardiovascular risk in young finns study
TAIMELA, S. P., Lehtimäki, T. J., Porkka, K. V. K., Räsänen, L., & Viikari, J. S. A. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90149-3 · Cited by 69
Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia
Austin, M. A., Horowitz, H., Wijsman, E. M., Krauss, R. M., & Brunzell, J. D. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90011-5 · Cited by 69
Self-citation
Familial lipoprotein disorders and premature coronary artery disease
Schaefer, E. J., Genest, J. J., Ordovás, J. M., Salem, D. N., & Wilson, P. W. F. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90152-x · Cited by 68
Linkage of the Cholesteryl Ester Transfer Protein ( CETP ) Gene to LDL Particle Size
Talmud, P. J., Edwards, K. L., Turner, C. M., Newman, B. M., Palmen, J., Humphries, S. E., & Austin, M. A. (2000) · Circulation · doi:10.1161/01.cir.101.21.2461 · Cited by 68
Self-citation
Defects of lipoprotein metabolism in familial combined hyperlipidaemia
Graaf, J. D., & Stalenhoef, A. F. H. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00002 · Cited by 68
Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families.
Graaf, J. D., Swinkels, D. W., de Haan, A. F., Demacker, P. N. M., & Stalenhoef, A. F. H. (1992) · Europe PMC (PubMed Central) · Cited by 68
Effects of Diet on High-Density Lipoprotein Cholesterol
Siri‐Tarino, P. W. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0207-y · Cited by 70
Lipid and Lipoprotein Biomarkers and the Risk of Ischemic Stroke in Postmenopausal Women
Berger, J. S., McGinn, A. P., Howard, B. V., Kuller, L. H., Manson, J. E., Otvos, J., Curb, J. D., Eaton, C. B., Kaplan, R. C., Lynch, J. K., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.641324 · Cited by 67
Effect of Intensive Glycemic Control on Fibrinogen, Lipids, and Lipoproteins
Emanuele, N. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.22.2485 · Cited by 66
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function
Båvenholm, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0752 · Cited by 67
Lipids and lipoproteins in symptomatic coronary heart disease. Distribution, intercorrelations, and significance for risk classification in 6,700 men and 1,500 women. The Bezafibrate Infarction Prevention (BIP) Study Group, Israel
(1992) · Circulation · doi:10.1161/01.cir.86.3.839 · Cited by 66
Families with Familial Combined Hyperlipidemia and Families Enriched for Coronary Artery Disease Share Genetic Determinants for the Atherogenic Lipoprotein Phenotype
Allayee, H., Aouizerat, B. E., Cantor, R. M., Dallinga‐Thie, G. M., Krauss, R. M., Lanning, C. D., Rotter, J. I., Lusis, A. J., & de Bruin, T. W. (1998) · The American Journal of Human Genetics · doi:10.1086/301983 · Cited by 66
Self-citation
Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?
Fonseca, M. I. H., da Silva, I. T., & Ferreira, S. R. G. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0221-5 · Cited by 68
Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes
Skyrme-Jones, R. A. P., O’Brien, R. C., Luo, M., & Meredith, I. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00547-1 · Cited by 65
“We observed reduced LDLPS to be a function of both high triglyceride levels and low HDL levels in agreement with previous findings (45).”
Result
Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years
Bosmans, J., Holvoet, P., Dauwe, S. E. H., Ysebaert, D., Chapelle, T., Jürgens, A., Kovacic, V., Marck, E. A. V., Broe, M. E. D., & Verpooten, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00752.x · Cited by 65
Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
Sosale, A., Saboo, B., & Sosale, B. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s49592 · Cited by 65
“(HDL-C), and hypertriglyceridemia.(2) Strong clinical evidence from multiple studies has demonstrated that all components of ADD are important risk factors for development of CVD.”
Background
Increased susceptibility to low density lipoprotein oxidation in women with a history of pre-eclampsia
Gratacós, E., Casals, E., Gómez, O., Llurba, E., Mercader, I., Cararach, V., & Cabero, L. S. (2003) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.02349.x · Cited by 64
Insulin Resistance and Human Disease: A Short History
Reaven, G. M. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.387 · Cited by 65
The effect of insulin sensitizer, troglitazone, on lipoprotein lipase mass in preheparin serum
Shirai, K., Itoh, Y., Sasaki, H., Totsuka, M., Murano, T., Watanabe, H., & Miyashita, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00063-7 · Cited by 64
LDL Subclass Patterns and Lipoprotein Response to a Low-Fat, High-Carbohydrate Diet in Women
Dreon, D. M., Fernstrom, H. A., Williams, P. T., & Krauss, R. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.4.707 · Cited by 64
Self-citation
Small dense low-density lipoprotein particles: clinically relevant?
Krauss, R. M. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000824 · Cited by 64
“The assessment of the relationship of sdLDL to ASCVD risk is confounded by the fact that this LDL category is a component of a lipoprotein phenotype that includes elevated levels of triglycerides and very low density lipoproteins (VLDLs) and reduced levels of high-density lipoprotein (HDL)cholesterol [10], and it is c…”
BackgroundSelf-citation
Pediatric triglycerides predict cardiovascular disease events in the fourth to fifth decade of life
Morrison, J. A., Glueck, C. J., Horn, P. S., Yeramaneni, S., & Wang, P. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.009 · Cited by 63
“High TG are associated with an increased population of small dense LDL particles that are highly atherogenic and can be oxidatively modified [49,50].”
Background
Lipid Parameters Including Lipoprotein (A) in Patients Undergoing CAPD and Hemodialysis
Siamopoulos, K. C., Elisaf, M., Bairaktari, H. T., Pappas, M. B., Sferopoulos, G., & Nikolakakis, N. G. (1995) · Peritoneal Dialysis International · doi:10.1177/089686089501500410 · Cited by 63
“This small dense LDL subclass pattern (designated pattern B) has been linked to the risk of coronary heart disease in nonuremic patients (38,39).”
Background
Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?
Nolan, D. A., Watts, G. F., Herrmann, S., French, M. A., John, M., & Mallal, S. A. (2003) · QJM · doi:10.1093/qjmed/hcg145 · Cited by 63
LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
Vakkilainen, J., Jauhiainen, M., Ylitalo, K., Nuotio, I. O., Viikari, J. S. A., Ehnholm, C., & Taskinen, M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31489-9 · Cited by 63
Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia
Cheung, M. C., Austin, M. A., Moulin, P., Wolf, A. C., Cryer, D., & Knopp, R. H. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90089-d · Cited by 63
Self-citation
Low-density lipoprotein and oxidised low-density lipoprotein: Their role in the development of atherosclerosis
Hamilton, C. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00202-1 · Cited by 62
Relationship of low-density lipoprotein particle size and measures of adiposity
Rainwater, D. L., Mitchell, B. D., Comuzzie, A., & Haffner, S. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800813 · Cited by 62
Metabolic Consequences of Obesity and Body Fat Pattern: Lessons from Migrant Studies
McKeigue, P. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514962.ch4 · Cited by 62
Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths
Kang, H.-S., Gutin, B., Barbeau, P., Litaker, M., Allison, J., & Le, N. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802045 · Cited by 61
Low density lipoprotein particle size and risk factors of insulin resistance syndrome
Friedlander, Y., Kidron, M., CASLAKE, M. J., Lamb, T. J., McConnell, M., & Bar-On, H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00215-4 · Cited by 60
“malities [1,7–10].”
BackgroundResultInfluential
Plasma proteomics to identify biomarkers – application to cardiovascular diseases
Beck, H. C., Overgaard, M., & Rasmussen, L. M. (2015) · Translational Proteomics · doi:10.1016/j.trprot.2015.01.001 · Cited by 62
Hypertriglyceridemia: new insights and new approaches to pharmacologic therapy
Ginsberg, H. N. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01489-8 · Cited by 61
Effects of pioglitazone on lipid and lipoprotein profiles in patients with type 2 diabetes and dyslipidaemia after treatment conversion from rosiglitazone while continuing stable statin therapy
Berhanu, P., Kipnes, M. S., Khan, M. A., Perez, A. T., Kupfer, S., Spanheimer, R. G., Demissie, S., & Fleck, P. R. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.005 · Cited by 60
“Apolipoprotein B, the protein moiety of LDL and VLDL, also was significantly decreased with reductions in LDL and VLDL particle concentrations, as expected.(23) Apolipoprotein B has been shown prospectively to be an independent risk factor for ischaemic heart disease.”
Background
Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans
Austin, M. A., Talmud, P. J., Farin, F. M., Nickerson, D. A., Edwards, K. L., Leonetti, D. L., McNeely, M. J., Viernes, H.-M. A., Humphries, S. E., & Fujimoto, W. Y. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.10.003 · Cited by 60
Self-citation
In Vivo Insulin Sensitivity and Lipoprotein Particle Size and Concentration in Black and White Children
Burns, S. F., Lee, S., & Arslanian, S. A. (2009) · Diabetes Care · doi:10.2337/dc09-0380 · Cited by 59
“genic lipoprotein pattern in adults with coronary artery disease (10,11).”
BackgroundInfluential
Insights Into the Pathogenesis and Prevention of Coronary Artery Disease
O’Keefe, J. H., Lavie, C. J., & McCallister, B. D. (1995) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64669-7 · Cited by 55
Long‐chain n‐3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state
Roche, H. M., & Gibney, M. J. (1999) · Lipids · doi:10.1007/bf02562313 · Cited by 59
Low Density Lipoprotein Particle Size and Risk of Early-Onset Myocardial Infarction in Women
Kamigaki, A. S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.10.939 · Cited by 59
“The interrelations between triglyceride, HDL cholesterol, and LDL particle size may reflect the “atherogenic lipoprotein phenotype” (32), in which small, dense LDL is associated with a variety of other lipoprotein risk factors, including increased plasma triglyceride, increased apolipoprotein B, lower HDL cholesterol,…”
Background
Women have a larger and less atherogenic low density lipoprotein particle size than men
Nikkilä, M. T., Pitkäjärvi, T., Koivula, T. A., Solakivi, T., Lehtimäki, T. J., Laippala, P. J., Jokela, H., Lehtom̈aki, E., Seppä, K., & Sillanaukee, P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05645-9 · Cited by 59
High Dietary Fructose Intake on Cardiovascular Disease Related Parameters in Growing Rats
Yoo, S., Ahn, H., & Park, Y. K. (2016) · Nutrients · doi:10.3390/nu9010011 · Cited by 57
“Also, chronic exposure of dyslipidemia has a major effect on cardiovascular disease (CVD) [15].”
Background
A unique genetic and biochemical presentation of fish-eye disease.
Kuivenhoven, J. A., Voorst, E. V. V. T., Wiebusch, H., Marcovina, S. M., Funke, H., Assmann, G., Pritchard, P. H., & Kastelein, J. J. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118348 · Cited by 58
LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I
Tan, K. C. B., Shiu, S. W. M., Janus, E. D., & Lam, K. S. L. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06015-7 · Cited by 58
N-3 fatty acids and diabetes
Sirtori, C. R., & Galli, C. L. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00255-x · Cited by 58
Visceral obesity and the risk of ischaemic heart disease: insights from the Québec Cardiovascular Study
Lamarche, B., Lemieux, S., Dagenais, G. R., & Després, J. (1998) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(98)80018-x · Cited by 59
Alterations in low-density lipoprotein and high-density lipoprotein subclasses among hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors
Legro, R. S., Blanche, P. J., Krauss, R. M., & Løbo, R. A. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00401-x · Cited by 57
Self-citation
Flaxseed oil intake reduces serum small dense low-density lipoprotein concentrations in Japanese men: a randomized, double blind, crossover study
Kawakami, Y., Yamanaka-Okumura, H., Naniwa-Kuroki, Y., Sakuma, M., Taketani, Y., & Takeda, E. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0023-2 · Cited by 61
“Sd-LDL is a risk factor for the development of coronary artery disease in Westerners [4,5] and Japanese with relatively low LDL cholesterol concentrations [6,7].”
Background
Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment
Ponte-Negretti, C. I., Isea-Perez, J. E., Lorenzatti, A. J., López-Jaramillo, P. A., Wyss-Q, F. S., Pintó, X., Lanas, F. T., Medina, J., Machado-H, L. T., Mónica Acevedo, B., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.059 · Cited by 66
Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men
Kazumi, T., Kawaguchi, A. T., Hozumi, T., Nagao, M., Iwahashi, M., Hayakawa, M., 石原, 健., & Yoshino, G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00201-9 · Cited by 57
Naringin Ameliorates Atherogenic Dyslipidemia but not Hyperglycemia in Rats With Type 1 Diabetes
Xulu, S., & Owira, P. M. O. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31823827a4 · Cited by 54
A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.
Lemieux, I., Laperrière, L., Džavík, V., Tremblay, G., Bourgeois, J., & Despres, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00711-0 · Cited by 63
“Among others, the presence of small, dense LDL particles have been associated with elevated triglyceride (TG) levels and reduced high density lipoprotein (HDL) cholesterol concentrations [16,18,20] as well as an increased ratio of total cholesterol/HDL cholesterol, a lipid index commonly used to globally estimate CHD…”
Background
Functional food science and substrate metabolism
Saris, W. H. M., L., N. G., Björck, I., Blaak, E. E., Bornet, F. R. J., Brouns, F. J. P. H., Frayn, K. N., Fürst, P., Riccardi, G., Roberfroid, M. B., et al. (1998) · British Journal Of Nutrition · doi:10.1079/bjn19980105 · Cited by 55
“There is evidence for a genetic component (Austin et al. 1990; Mitchell et al. 1996).”
Background
Metabolic Effects of Protease Inhibitor-Sparing Antiretroviral Regimens Given as Initial Treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)
Shikuma, C. M., Yang, Y., Glesby, M. J., Meyer, W. A., Tashima, K. T., Ribaudo, H. J., Webb, N., Bastow, B., Kuritzkes, D. R., & Gulick, R. M. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318031d5a0 · Cited by 55
The metabolic basis of atherogenic dyslipidemia
Vinik, A. I. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80065-1 · Cited by 55
“* emia because they are: (1) primary features of this form of dyslipidemia; (2) associated with insulin resistance, detectable early in the development of the metabolic syndrome; (3) individually highly inherited; and (4) relatively simple to quantify.”
Background
Lipoprotein subclasses and atherosclerosis.
Superko, R. (2001) · Frontiers in Bioscience · doi:10.2741/superko · Cited by 52
Caloric Restriction in Rhesus Monkeys Reduces Low Density Lipoprotein Interaction with Arterial Proteoglycans
Edwards, I. J., Rudel, L. L., Terry, J. G., Kemnitz, J. W., Weindruch, R. H., & Cefalu, W. T. (1998) · The Journals of Gerontology Series A · doi:10.1093/gerona/53a.6.b443 · Cited by 56
“Although the relationship of LDL particle size to atherosclerosis in monkeys may be species- and diet-dependent, the present study in rhesus monkeys is consistent with reports in humans that lower plasma TG are associated with less atherogenic LDL (28-30,32).”
BackgroundResult
Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism
Packard, C. J. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00006 · Cited by 55
Oxidation of low density lipoprotein in patients on regular haemodialysis
Loughrey, C. M., Young, I. S., McEneny, J., McDowell, I., McMaster, C., McNamee, P., & Trimble, E. R. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90203-8 · Cited by 55
Effect of Fluvastatin Slow-Release on Low Density Lipoprotein (LDL) Subfractions in Patients with Type 2 Diabetes Mellitus: Baseline LDL Profile Determines Specific Mode of Action
Winkler, K., Abletshauser, C., Hoffmann, M. M., Friedrich, I., Baumstark, M. W., Wieland, H., & März, W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020370 · Cited by 55
Correction of Hyperandrogenemia by Laparoscopic Ovarian Cautery in Women with Polycystic Ovarian Syndrome Is Not Accompanied by Improved Insulin Sensitivity or Lipid-Lipoprotein Levels1
Lemieux, S., Lewis, G. F., Ben‐Chetrit, A., Steiner, G. A., & Greenblatt, E. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6140 · Cited by 54
All Low-Density Lipoprotein Particles Are Not Created Equal
Krauss, R. M. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303458 · Cited by 55
Self-citation

Authors: Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M.
Affiliations: University of California, Berkeley (US)
ORCID: King, M C
Krauss, R M
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1990-08
Volume: 82
Issue: 2
Pages: 495-506
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.82.2.495
OpenAlex: W2089286420
Cited by: 1,411
References: 63
Citations by year: 2026: 11 · 2025: 15 · 2024: 17 · 2023: 39 · 2022: 20 · 2021: 26 · 2020: 25 · 2019: 27 · 2018: 17 · 2017: 21 · 2016: 27 · 2015: 42 · 2014: 38 · 2013: 46 · 2012: 39
FWCI: 47.63
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Energy (DE-AC03-?, AC03-76SF00098, DEAC03-76SF00098)
National Institutes of Health (7r29hl038760-03, 5p01hl018574-26, DE-AC03- 76SF00098)
National Heart, Lung, and Blood Institute (HL38760, HL-18574)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: atherogenic lipoprotein phenotype, LDL subclasses, low-density lipoprotein, coronary heart disease risk, genetic markers, single-gene inheritance, apolipoprotein B, apolipoprotein A-I, HDL cholesterol, HDL2, triglycerides, VLDL, intermediate density lipoprotein
MeSH terms: Adolescent, Adult, Aged, Arteriosclerosis, Child, Child, Preschool, Chromosome Mapping, Coronary Disease, Female, Genetic Markers, Humans, Lipids, Lipoproteins, Cholesterol, HDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks